Literature DB >> 30868832

[Regularity of traditional Chinese medicine prescriptions for same treatment for cardiovascular and cerebrovascular diseases].

Jia-Ming Gao1, Ming Lyu1, Wei-Wei Xie1, Xin-Yan Liu1, Bu-Chang Zhao2, Yan Zhu1.   

Abstract

To explore the regularity of traditional Chinese medicine(TCM) prescriptions for cardio-cerebrovascular diseases,the core drug groups with common therapeutic effects on cerebrovascular diseases represented by stroke and cardiovascular diseases represented by coronary artery disease were extracted,and their consistency and difference in the treatment of different diseases were analyzed.A total of 388 Chinese patent medicines were collected for the treatment of cerebrovascular diseases,cardiovascular diseases and cardio-cerebrovascular diseases.The dominant and recessive patterns of Chinese patent medicines in clinical use were found by "frequency analysis","compatibility analysis" and "network analysis" respectively.According to the findings of the three parts,Salviae Miltiorrhizae Radix et Rhizoma,Chuanxiong Rhizoma,Carthami Flos and Astragali Radix have a high frequency of use in the treatment of brain disease,heart disease and both,with frequent combined medication.Data mining confirmed the core drug combinations for the treatment of cerebral and cardiac vascular diseases,so as to reveal the similarities and differences in the drug use of Chinese medicine for these diseases,and provide a basis for the rational use of traditional Chinese medicine in clinical practice.This analysis also defines a new direction for the future development of prescription combinations for different indications of cerebral and cardiac diseases.

Entities:  

Keywords:  Chinese medicine prescription regularity; cardio-cerebral vascular disease cotreatment; traditional Chinese medicine inheritance system

Mesh:

Substances:

Year:  2019        PMID: 30868832     DOI: 10.19540/j.cnki.cjcmm.20181101.007

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Protective effects of liquiritin on polycystic ovary syndrome through modulating ovarian granulosa cell proliferation and apoptosis via miR-206/PI3K/AKT pathway.

Authors:  Xuan Cui; Shisan Zhou; Yongtao Lin
Journal:  Cytotechnology       Date:  2022-03-21       Impact factor: 2.040

Review 2.  Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke.

Authors:  Ting Zhu; Lei Wang; Yicheng Feng; Guibo Sun; Xiaobo Sun
Journal:  Oxid Med Cell Longev       Date:  2021-03-13       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.